Bioengineering / Biyomühendislik

Permanent URI for this collectionhttps://hdl.handle.net/11147/4529

Browse

Search Results

Now showing 1 - 3 of 3
  • Conference Object
    Short Lecture "method Development for Pilot Production of Astragaloside Vii"
    (Georg Thieme Verlag, 2022) Kurt, Mustafa Ünver; Tağ, Özgür; Bedir, Erdal
    Based on the promising immunostimulant effect comparable to commercialized adjuvants Alum and Quillaja saponins (including QS-21) [1], [2], [3], our team has been prompted to carry out advance studies for developing Astragaloside VII (AST VII) ([Fig. 1]) as a new vaccine adjuvant or an immunotherapeutic agent. Hence, one of the most critical challenges is establishing efficient isolation and purification processes to obtain AST VII on a large scale. Thus, this study aimed to develop a production methodology for AST VII from Turkish Astragalus species.
  • Article
    Citation - WoS: 5
    Citation - Scopus: 6
    Undescribed Polyether Ionophores From Streptomyces Cacaoi and Their Antibacterial and Antiproliferative Activities
    (Elsevier, 2022) Gezer, Emre; Üner, Göklem; Küçüksolak, Melis; Kurt, Mustafa Ünver; Doğan, Gamze; Ballar Kırmızıbayrak, Petek; Bedir, Erdal
    Polyether ionophores represent a large group of naturally occurring compounds mainly produced by Streptomyces species. With previously proven varieties of bioactivity including antibacterial, antifungal, antiparasitic, antiviral and anti-tumor effects, the discovery of undescribed polyethers leading to development of efficient therapeutics has become important. As part of our research on polyether-rich Streptomyces cacaoi, we previously performed modification studies on fermentation conditions to induce synthesis of specialized metabolites. Here, we report four undescribed and nine known polyether compounds from S. cacaoi grown in optimized conditions. Antimicrobial activity assays revealed that four compounds, including the undescribed (6), showed strong inhibitory effects over both Bacillus subtilis and methicillin-resistant Staphylococcus aureus (MRSA) growth. Additionally, K41-A and its C15-demethoxy derivative exhibited significant cytotoxicity. These results signified that selectivity of C15-demethoxy K41-A towards cancer cells was higher than K41-A, which prompted us to conduct mechanistic experiments. These studies showed that this uninvestigated compound acts as a multitarget compound by inhibiting autophagic flux, inducing reactive oxygen species formation, abolishing proteasome activity, and stimulating ER stress. Consequently, the optimized fermentation conditions of S. cacaoi led to the isolation of undescribed and known polyethers displaying promising activities.
  • Conference Object
    A Validated Uhplc-Cad Method for Quantitative Determination of Astragaloside Vii
    (Georg Thieme Verlag, 2019) Kurt, Mustafa Ünver; Tağ, Özgür; Bedir, Erdal
    Astragaloside VII (AST VII) [Fig 1], the first tridesmosidic saponin identified in nature [1], possesses potent immunostimulatory/adjuvant effects [2]. Based on the promising adjuvant properties comparable to current adjuvants (i.e. Alum and QS-21), our team has decided to carry out further studies on AST VII including semi-synthesis studies to discover and develop new human/animal vaccine adjuvants [2]–[5]. Since more than 450 Astragalus species grow wildly in Turkish flora, one of the first challenges of this adjuvant development project is to examine these species by efficient analytical methods to find AST VII rich plant materials and select the rich species for possible cultivation and/or pilot production studies. Thus, aim of this study was to develop a UHPLC method coupled with the Charged Aerosol Detector (CAD) in order to determine AST VII content simultaneously, precisely and sensitively in Astragalus samples. A fifteen minutes method was developed using C18 (100 mm x 4 mm x 3 µm) column, eluting with gradient Water:Acetonitrile mixtures at 0.75 mL/min flow rate. The linear regression analysis of calibration plots showed good linear relationship with r 2=0.9995 in concentrations ranging from 52 to 208 μg/mL. The method was validated for its calibration curve, specificity, precision and robustness. The recovery was found to be in the range of 98.17 to 101.86%. As a conclusion, for the first time, a UHPLC method was validated to quantify AST VII utilizing CAD for its detection.